Orchid receives a EU marketing authorisation for generic Zosyn
This article was originally published in Scrip
Executive Summary
Orchid Chemicals and Pharmaceuticalshas received a marketing authorisation for piperacillin and tazobactam for injection in the EU. The product is a generic version ofWyeth’s antibiotic, Zosyn.